Total occlusion (TO) of the culprit artery usually presents with ST-elevation myocardial infarction. A subset of patients with TO present as non-ST segment elevation myocardial infarction (NSTEMI) without classic ST-elevation on the electrocardiogram. This may lead to delay in identification of these patients and further management. We performed a meta-analysis to estimate the difference in outcomes between totally occluded and non-occluded culprit arteries in patients with NSTEMI.
Introduction
Acute coronary syndrome (ACS) is a major cause of mortality and morbidity. [1] [2] [3] The spectrum of ACS includes ST-segment elevation myocardial infarction (STEMI), non-ST segment elevation myocardial infarction (NSTEMI), and unstable angina. The electrocardiogram (ECG) plays an important role in identifying and differentiating STEMI from NSTEMI. ST-elevation on an ECG helps in recognition of total occlusion (TO) of the culprit artery, and its presence is an indication for immediate coronary angiography and revascularization. However, in clinical practice, a subset of patients found to have TO of the culprit artery based on invasive coronary angiography, present as NSTEMI with elevated biomarkers and without classic ST-elevation on routine ECG. 4, 5 This is more commonly reported in patients presenting with either right coronary artery or left circumflex artery involvement. [6] [7] [8] [9] [10] [11] [12] Current clinical practice guidelines recommend an emergent invasive strategy (door-to-balloon time within 90 min) for patients with STEMI based on clinical and ECG findings. 13 However, due to lack of classic ECG findings, these NSTEMI patients, despite TO of the culprit artery may be missed leading to either delay in or no revascularization. 14 We performed a systematic review and meta-analysis of available studies to estimate the difference in clinical outcomes of patients with NSTEMI and TO compared with NSTEMI and non-TO (Central Figure) .
Methods
Search strategy, study eligibility, and data extraction
We followed reporting items for systematic review and meta-analysis (PRISMA) guidelines for this systematic review. 15 Two authors (A.R.K., H.G.) developed the search strategy with help of a librarian (M.A.). MEDLINE (Ovid) and EMBASE (Elsevier) were searched from database inception to 14 September 2016. The initial keywords along with MeSH or Emtree terms used included: non-ST elevation acute coronary syndrome, non-ST elevation myocardial infarction, NSTEMI, NSTE-ACS, acute TO, occluded coronary artery, acute coronary occlusion, mortality, outcomes, in-hospital mortality, and long-term mortality. References of the studies found were also assessed for other potential studies. Two authors (A.T., C.B.) independently reviewed titles and abstracts of all studies and selected studies as per our pre-defined eligibility criteria. There was no restriction of language or inclusion of published abstracts in our analysis. The studies, which fulfilled the eligibility criteria were those which compared clinical characteristics and outcomes of patients who present with NSTEMI and have either, totally occluded vs. non-occluded or partially occluded culprit artery. Any disagreements were resolved through discussion. Two authors (A.R.K., H.G.) extracted data from the selected studies independent of each other. Extracted data included characteristics of study population, associated co-morbid diseases, and relevant outcomes.
Outcomes of interest
The clinical outcomes of interest were all-cause mortality and major cardiac adverse events (MACE). The definition of MACE followed the outcome as defined in each study. The clinical outcomes measured were divided as short-term (in-hospital or 30-day) or medium to long-term (6-12 months). Other parameters measured at presentation which may have an effect on initial management strategy and subsequent outcomes were: clinical features as measured by the Killip class, left ventricular ejection fraction (LVEF) as measures of severity of presentation and time to angiography or percutaneous coronary intervention (PCI).
Statistical analysis
The data were reported as either mean ± standard deviation or percentage. The difference between the groups was calculated by Fisher's exact or v 2 test where appropriate. Adjusted relative risk (RR) or hazards ratio (HR) reported by individual studies were used in the analyses. Relative risk was calculated from dichotomous outcomes when no adjusted outcomes were reported. A cumulative RR was calculated by pooling the RR or HR reported from the studies for all-cause mortality and MACE separately. The inverse-variance method was used to pool the effect-estimate in a fixed or random-effects model based on the associated heterogeneity. We pooled RR and HR together because they may be regarded as similar measures of association if the risk of the event does not vary greatly over time. 16 To attenuate the change in risk over time, we calculated mortality and MACE at two time points (in-hospital/30 day and 6-12 months). Subgroup analysis was also performed to find any difference between the two measures of association (RR and HR). Weighted mean difference (MD) was calculated to find the difference between LVEF between the two groups. The Mantel-Haenszel method was used to pool the difference in clinical presentation (measured by Killip class) between the two groups. Sensitivity analysis was also performed with one-study removal analysis to assess the role of individual studies on the effect-estimate. The associated heterogeneity was assessed by the I 2 statistic.
Publication bias was not assessed as there were only a small number of studies (<10). All analyses were conducted using the statistical software Review Manager (v5.2) and Comprehensive meta-analysis (version 3).
Quality assessment
Two authors (A.B.A., A.R.K.) via Newcastle-Ottawa Scale (NOS) assessed the methodological quality of the included cohort studies. This scale involves evaluation based on three areas; selection of the study groups, comparability among groups, and the assessment of outcome between the groups. 17 The scale assigns a maximum of 4 points for selection, 2 points for comparability, and 3 points for exposure/outcome assessment. Studies with >7 points were considered of high quality and studies with <5 points were considered low quality. The overall evidence was then evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. 18 This approach evaluates the evidence based on the methodological quality, directness of evidence, precision of estimate, heterogeneity, publication bias, effect size, and plausible explanation of the confounding or bias. Using this framework, the quality of evidence is graded on the extent the calculated effect-estimate may be close to the true effect-estimate.
Results

Identification of studies
Seven studies [6] [7] [8] [9] [10] [11] [12] were included in the study out of 277 publications identified from the literature search (see Supplementary material online, Figure S1 ). All the studies were observational in nature; four were from cardiovascular registries, 6,9,10,12 two were post hoc analyses 7,11 of randomized trials and one was a prospective study. 8 In all the studies, the patient cohort was representative of the general population with both the TO and non-TO groups derived from the same population. The groups were comparable and effect estimate was adjusted for confounders in the individual analyses. The followup was adequate and the outcomes were not present in any of the studies prior to start of the study. Overall, the observational studies included in the analysis had good methodological quality with NOS score > _7 (see Supplementary material online, Table S1 ). Supplementary material online, Table S2 summarizes the characteristics of the studies included in the analysis.
Study population
A total of 40 777 patients were included in the analysis, of whom 10 415 (25.5%) patients had TO of the culprit artery while 30 362 (74.5%) had non-occluded vessels. Most of the patients included in the studies were male with an average age of 63 years. The study population was comparable in terms of age, sex, and other comorbidities in all studies except in the study by Dixon and colleagues in which the patients with TO were younger compared with the non-TO group 6 (see Supplementary material online, Table S3 ).
The culprit artery was identified and defined in six studies based primarily on angiographic findings, [7] [8] [9] [10] [11] [12] and in one study based on the first lesion attempted. 6 In three studies, ECG and echocardiogram also supported angiography in assessment of the culprit artery. 9, 10, 12 The angiographic assessment and ascertainment of the culprit artery was done by the treating physician and was validated in two studies: either by an independent core lab 11 or by two other experienced cardiologists who were blinded to the clinical presentation. 8 There was difference in anatomical distribution of the culprit artery between the TO and non-TO group; the right coronary artery (TO: 40%, non-TO: 27%, P <0.0001) was the most commonly involved culprit vessel in the TO group followed by left circumflex artery (TO: 32%, non-TO: 28%, P <0.0001) and left anterior descending artery (TO: 28%, non-TO: 44%, P <0.0001) (see Supplementary material online, Tables S3 and S4).
Presenting features
Both groups were compared in terms of high-risk clinical features (Killip class III/IV), changes in ECG and left ventricular systolic function (LVEF) at the time of presentation. Five studies [7] [8] [9] [10] 12 reported the Killip class at presentation. Our analysis showed no difference in Killip class III/IV (RR: 1.13, CI: 0.95, 1.35, P = 0.16; I 2 = 19%) at the time of presentation between the two groups ( Figure 1, upper panel) .
There was lack of classic ST-elevation on ECG of these patients; however other ECG changes were reported. Only four studies 7, 9, 11, 12 reported the changes in ECG at the time of presentation.
The ECG changes described were T wave inversion, ST-depression, and presence of Q waves in more than two contiguous leads. In the study by Warren et al., 11 they found an increased incidence of ST-depression > _1 mm in patients with TO (P = 0.0007) while Wang et al. 7 found similar incidence of ST-depression > _1 mm in patients with TO and non-TO (P = 0.36). However, Wang et al. did find an increased incidence of Q waves in patients with TO (P = 0.0004). Six studies, [7] [8] [9] [10] 11, 12 reported myocardial injury at the time of presentation as measured by biomarker elevation [creatine kinase MB fraction (CK-MB), troponin-I, or troponin-T levels]. There was significant variability in the levels of CK-MB and troponin as different units were used to measure them and they were measured at different time-points in the individual studies, hence the results were not pooled. However, three studies reported statistically significant differences between the two groups, with increased biomarker levels found in patients with TO. Six studies evaluated LVEF in the analysis, out of which four studies 8, [10] [11] [12] reported mean LVEF at presentation and two studies 7, 9 reported the percentage of patients with LV dysfunction in patients with occluded arteries and non-occluded arteries. A meta-analysis of the four studies which reported LVEF suggested that the LV function was worse in patients who had TO (MD -1.95, CI: -3.18, -0.72, P = 0.002; I 2 = 68%) ( Figure 1, lower panel) . This was limited by substantial heterogeneity between the studies. Out of the two studies which reported the percentage of patients with LV dysfunction, one reported worse LV function 7 in patients with TO and one study reported no difference between TO and non-TO groups. 
Time to angiography or percutaneous coronary intervention
Six studies 7-12 reported time to angiography or PCI of which three studies reported time from hospital arrival to angiography, 7,8,11 two reported time from hospital arrival to PCI 10, 12 and one reported time from symptom onset to PCI. 9 Time as a factor does not have normal distribution; hence the studies were not pooled to evaluate the difference in time to angiography. However, in all the studies the mean time to angiography or PCI was more than 24 h (TO: 31.3 h; non-TO: 34.2 h). In only one study, angiography/PCI was done early (within 6 h) in both the groups. There was no significant difference in the time to angiography in the individual studies.
Only two studies 8, 11 reported the presence or absence of collaterals, which were found to be increased in patients who present with TO. There was no difference in rates of revascularization between the two groups [TO: 1875/2226 (84.2%); non-TO: 3409/4079 (83.5%)] (P = 0.49) among the studies that reported revascularization rates.
Major cardiac adverse events
Individual studies defined MACE differently. Three studies 9-11 defined MACE as death, non-fatal myocardial infarction, or target vessel revascularization. MACE was calculated in one study from the reported incidence of death, MI, and target vessel revascularization. 12 One study 8 included admission for unstable angina along with death and re-infarction in the definition of MACE, and one study 7 included death and non-fatal MI as MACE. A total of six studies 7-9,11,12 reported MACE, with five studies 7-9,11,12 reporting both short-and medium-to long-term MACE, while one study 10 reported short-term events only. Our analysis suggested an increased risk of MACE in the shortterm with TO of the culprit artery (RR: 1.41; CI: 1.17, 1.70; P = 0.0003; I 2 = 26%) with mild heterogeneity. Subgroup analysis showed the increased risk of short-term MACE persisted in both measures of association (HR: 1.34; CI: 1.04, 1.74; P = 0.02; I 2 = 29%
and RR: 1.49; CI: 1.07, 2.09; P = 0.02; I 2 = 45%) ( Figure 2) . Sensitivity analysis performed with the one-study removal analysis showed minor variability in the pooled effect-estimate (RR: 1.35 to 1.52; CI: 1.05 to 1.27, 1.67 to 1.82).
In the medium-to long-term, the analysis demonstrated an increased incidence of MACE events with TO of the culprit artery (RR: 1.32; CI: 1.11, 1.56; P = 0.001; I 2 = 25%) associated with mild heterogeneity (Figure 3 ). Subgroup analysis also demonstrated an increased risk of short-term MACE with the reported effect estimate of HR (HR: 1.42; CI: 1.04, 1.93; P = 0.03; I 2 = 55%) and a trend towards increased risk of short-term MACE with the reported effect estimate of RR (RR: 1.23; CI: 0.98, 1.53; P = 0.07; I 2 = 0%) ( Figure 3 ).
Sensitivity analysis showed only minor changes with the one-study removal analysis (RR: 1.22 to 1.36; CI: 1.03 to 1.15, 1.45 to 1.68).
All-cause mortality
Seven studies [6] [7] [8] [9] [10] [11] [12] reported all-cause mortality out of which one study reported short-term mortality only 6 ; one study reported medium-to long-term mortality only 10 ; and five studies reported both shortterm and medium-to long-term mortality. [7] [8] [9] 11, 12 Overall, six studies reported short-term mortality [6] [7] [8] 11, 12 and six studies reported medium to long-term mortality.
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Our meta-analysis showed increased short-term mortality with TO of the culprit artery with moderate heterogeneity (RR: 1.67; CI: 1.31, 2.13; P < 0.0001; I 2 = 41%). Subgroup analysis showed a difference be- 
Discussion
The results of our meta-analysis suggest that NSTEMI patients who present with TO may represent a higher risk group as they may suffer from impaired LV function and increased risk of both short-term and medium-to long-term MACE and all-cause mortality. Despite the increased risk of mortality or MACE, we did not find any significant difference in high-risk clinical features (Killip class III/IV) between the two groups at the time of presentation, perhaps because the majority of patients included were all presenting with their first MI. Although, we did not pool the differences in biomarker level because of the associated variability as discussed above, the qualitative analysis suggested that there may be an increased burden of myocardial injury in the patients with TO. This lack of high-risk clinical features resulted in no difference in time to angiography or PCI between the two groups. Moreover, both the groups were out of the early invasive window period at the time angiography was performed. 19, 20 Prior studies have shown that outcomes of patients with TO without ST-elevation are inferior to even STEMI patients historically, who present with TO but have characteristic electrocardiographic changes leading to timely revascularization. 14, 21 Although the exact reasons for the absence of characteristic ECG changes cannot be elucidated by our analysis, there may be several possibilities. First, the ECG has decreased sensitivity to show changes of TO in the inferolateral distribution. It is quite likely that this group of NSTEMI patients may really represent a subset of STEMI patients, not recognized effectively by the 12-lead ECG screen. Second, there is a possibility that transient ST-elevation may be missed by the routine 12-lead ECG monitoring in patients who have an occlusive thrombus, which resolves by spontaneous recanalization or after medical therapy. In such patients, resolution of the ST-segment elevation would correlate with clinical reperfusion and improvement in TIMI flow. 22 In our analysis, all the included patients demonstrated TO with TIMI 0-1 flow which suggests that transient ST-elevation with spontaneous reperfusion was less likely to have occurred. Third, there is a possibility of a slowly developing occlusive thrombus along with adequate collateral flow leading to only subendocardial ischaemia as opposed to transmural infarction. However, except for one study, 8 none of the other studies reported associated collateral flow, which may therefore suggest acute occlusion in the majority of patients included in our study. In the one study, that reported collateral flow, it was found in only 18% patients with TO. 8 In addition, the presence of a chronic TO would not lead to the typical 'rise and fall' pattern of biomarker release and myocardial injury as found in the included studies. Finally, in some of the included studies, patients with prior MI, multivessel disease and prior coronary artery bypass graft surgery were excluded which would decrease the likelihood of inadvertent inclusion of patients with chronic TOs.
To the best of our knowledge, this is the first systematic review and meta-analysis to evaluate outcomes in patients with TO of the presumed culprit artery, who present without typical ST-elevation. Our study has several potential clinical implications. Patients presenting with NSTEMI who have an occluded culprit vessel on coronary angiography represent a subset of ACS whose identification based on clinical and electrocardiographic criteria remains challenging. Current clinical practice guidelines recommend an emergent invasive strategy (within 2 h) for patients with either hemodynamic instability or features of ongoing ischemia and an early invasive strategy (within 24 h) for high-risk patients with GRACE risk score > 140, temporal change in troponins, dynamic ST-changes, or prior coronary revascularization. 19, 20, 23, 24 Although, patients with TO of the culprit artery would likely benefit from an emergent invasive approach; the absence of high-risk features and lack of characteristic ECG changes excludes them from such an approach. There was a mean delay of more than 24 h for an invasive procedure in almost all the included studies in our analysis. To be able to identify these patients early, awareness about these patients will be helpful. One of the most important modalities to help identify these patients may be ECG changes especially in the infero-lateral distribution involving the left circumflex artery/right coronary artery distribution. Although not evaluated in the studies included in our analysis, some ECG changes which have been reported to suggest TO, such as the presence of ST-depression in the precordial leads, especially V1-V3, may be suggestive of an occlusive thrombus compared with similar changes in the lateral precordial leads for the involvement of the left circumflex artery. 5 Also employing tools such as extreme lateral leads V7-V8 or V4R 25 and body surface mapping potentials 26 would be helpful, but modestly so along with repeated ECGs in order not to miss any dynamic or transient ECG changes. In addition, point-of-care echocardiography with speckle tracking performed in a protocol-based manner may aid in the early identification of these patients who are at a high-risk for adverse outcomes. 27 It may be argued that in the absence of a reliable non-invasive modality to identify these patients and given the high incidence of TO in patients who present with NSTEMI, it would be logical to perform early angiography, especially in patients who present with infero-lateral ischaemia.
Our study has several limitations. The overall quality of evidence was low because of the risk of bias due to the observational design of the included studies, inconsistency of the results between the subgroups, indirectness of the results, confounding, and associated heterogeneity found in our meta-analysis. Furthermore, we were unable to assess for publication bias because of the limited number of studies in our analysis. The observational design in addition does not allow establishment of causation, and therefore our analysis should be considered as hypothesis generating. In addition to the design of the included studies, the evidence was affected by the presence of between-study heterogeneity. The results may have been affected by the differences in the baseline clinical characteristics of the patients Figure 4 Forest plot comparing all-cause mortality (short-term) in total occlusion of culprit artery in non-ST segment elevation myocardial infarction patients (IV, inverse-variance; TO, total occlusion; SE, standard error; CI, confidence interval). Figure 5 Forest plot comparing all-cause mortality (medium-to long-term) in total occlusion of culprit artery in non-ST segment elevation myocardial infarction patients (IV, inverse-variance; TO, total occlusion; SE, standard error; CI, confidence interval).
Outcomes with total occlusion of culprit artery in NSTEMI included in the individual studies, infarct size depending on the myocardium at risk, and the use of anti-platelet or anti-coagulant agents at presentation, which contribute to the variability in the results. However, this heterogeneity underscores the differences in the patient population who may present with TO and highlights the need to identify high-risk sub-groups. In addition, the presence of unadjusted outcomes may also have affected the results and contributed to the heterogeneity encountered in our analysis. Another limitation was the difficulty in assessment of the acuteness of the occlusion of the culprit artery. In the included studies, clinical profile, associated comorbid diseases, echocardiographic parameters, and the morphology of the lesion were used to determine the culprit vessel and the acuteness of the occlusion by the treating interventional cardiologist during angiography-as is customary in routine clinical practice. There was independent validation of the angiographic findings in only two studies. 8, 11 The lack of collateral flow would also be suggestive of an acute occlusion; however, the presence or absence of collateral flow was not known for most of the included studies.
Conclusion
Our analysis suggests that patients with NSTEMI who demonstrate TO of culprit vessel on coronary angiography represent a specific subset of ACS and are at higher risk of mortality and major adverse cardiac events. Better risk stratification tools are needed to identify such high-risk ACS patients to facilitate earlier revascularization and potentially to improve outcomes.
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